Related Experiment Video

Updated: Aug 11, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

Pharmacological management of renal fibrotic disease

Jens Gaedeke1, Hans-H Neumayer, Harm Peters

  • 1Department of Nephrology, Charité Universitätsmedizin Berlin, Campus Charité Mitte, Humboldt University, Schumannstrasse 20/21D-10098 Berlin, Germany. Jens.Gaedeke@charite.de

Expert Opinion on Pharmacotherapy
|March 1, 2006
PubMed

Insights

Chronic kidney disease progression involves pathological matrix expansion, driven by the renin-angiotensin and TGF-beta systems. This review covers current and future therapies targeting these pathways to manage kidney fibrosis.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pharmacology

Background:

  • Chronic kidney diseases (CKD) are a growing global health concern, often leading to end-stage renal failure.
  • Renal fibrosis, characterized by pathological matrix protein expansion, is a common pathway in CKD progression, irrespective of the initial cause.
  • Overactivity of the renin-angiotensin system (RAS) and the transforming growth factor-beta (TGF-β) system are identified as key drivers of kidney matrix accumulation.

Purpose of the Study:

  • To provide a comprehensive overview of established therapeutic options for managing chronic renal disease.
  • To highlight novel molecular strategies currently under investigation for future clinical application.
  • To discuss the role of the renin-angiotensin and TGF-beta systems in renal fibrosis and therapeutic targeting.

Main Methods:

  • Literature review of established and emerging therapies for chronic kidney disease.
  • Analysis of molecular mechanisms underlying renal fibrosis, focusing on the renin-angiotensin and TGF-beta pathways.
  • Synthesis of current clinical practices and future therapeutic directions in nephrology.

Main Results:

  • Established therapies primarily target the renin-angiotensin system and TGF-beta system to mitigate kidney matrix accumulation.
  • Emerging molecular strategies show promise in addressing the complex mechanisms of renal fibrosis.
  • Understanding these pathways is crucial for developing effective treatments to slow CKD progression.

Conclusions:

  • Therapeutic strategies for chronic kidney disease focus on inhibiting key mediators like the renin-angiotensin and TGF-beta systems.
  • Novel molecular approaches are being developed to combat renal fibrosis and improve patient outcomes.
  • Effective management of CKD requires targeting the underlying fibrotic processes and associated molecular pathways.

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...